Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of the Board of Directors of the Company ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Covidh Technologies Ltd, which is listed on BSE (Scrip Code: 534920), met on March 10, 2026 and approved several key changes. The company will change its name to 'iSERA Lifesciences Limited', with MCA approval for the new name already obtained, subject to shareholder approval by special resolution. The registered office is being shifted within Pune, from Shukrawar Peth to Sadhu Vaswani Chowk, Camp, effective March 10, 2026. The board recommended appointing four directors for five-year terms each: Mr. Dhairyasheel Vasantrao Yadav and Mr. Nandkumar Subhash Kadam as Executive Directors, and Mr. Pratap Dadasaheb Deshmukh and Ms. Ritu Dhanraj Garad as Non-Executive Directors. An Extraordinary General Meeting has been scheduled for April 2, 2026 to seek shareholder approval for these proposals.
The rebranding to 'iSERA Lifesciences' suggests a strategic pivot towards the pharmaceutical and life sciences sector, aligning with the new directors' biotech backgrounds. Shareholders should watch for the EGM outcome on April 2, 2026, as the name change and director appointments require their approval.